Characterization of a novel cell line established from mice gastrointestinal stromal model by chemical induction

Zhan Zhao1, Shenghui Qiu2, Xiangwei Zhang1

  • 1Department of General Surgery, The First Affiliated Hospital of Jinan University, 510632, Guangzhou, Guangdong, PR China.

Translational Oncology
|April 15, 2025
PubMed
Abstract

Insights

Researchers developed a new mouse model for gastrointestinal stromal tumors (GISTs) using a chemically induced cell line, mGSTc01. This model closely mimics human GIST and responds to imatinib, offering a platform for new cancer therapies.

Area of Science:

  • Oncology
  • Gastroenterology
  • Translational Research

Background:

  • Gastrointestinal stromal tumors (GISTs) are rare mesenchymal neoplasms.
  • Existing mouse models lack authentic GIST cell lines for comprehensive study.
  • Need for robust preclinical models to understand GIST pathogenesis and treatment.

Purpose of the Study:

  • To develop and characterize a novel, chemically induced mouse model for GIST.
  • To establish and validate a GIST cell line (mGSTc01) from this model.
  • To assess the therapeutic response of the GIST model to imatinib.

Main Methods:

  • Chemical induction of GIST in C57BL/6 J mice using 3-methylcholanthrene.
  • Histology, immunohistochemistry (IHC), and molecular profiling (WES, RNA-seq) of tumors and cell lines.
  • Establishment and characterization of the mGSTc01 cell line, including in vivo xenograft studies.

Main Results:

  • Successful development of a chemically induced murine GIST model with c-kit and DOG-1 expression.
  • The mGSTc01 cell line exhibited malignant behaviors (migration, adhesion, proliferation) and key mutations (Lamb1, MMP9, c-kit).
  • GIST xenografts in immunocompetent mice responded to imatinib, validating the model's therapeutic relevance.

Conclusions:

  • The mGSTc01 cell line, derived from a chemically induced GIST model, accurately mimics human GIST characteristics.
  • This novel cell line and mouse model provide a valuable platform for GIST research.
  • Enables further investigation into the tumor microenvironment and facilitates discovery of new GIST therapies.